Avita Medical | 1811094D - Market Capitalization



Avita Medical reported AUD176.45M in Market Capitalization this September of 2025, considering the latest stock price and the number of outstanding shares.


Market Capitalization Change Date
Clinuvel Pharmaceuticals AUD 603.73M 166.36M Dec/2024
Cochlear AUD 18.97B 2.79B Dec/2024
CSL AUD 136.34B 6.32B Dec/2024
Cspc Pharmaceutical HKD 57.03B 1.39B Mar/2025
Dianthus Therapeutics USD 692M 93M Sep/2025
Divis Laboratories Ltd 1.81T 277.71B Jun/2025
Kangmei Pharma CNY 26.2B 2.77B Jun/2025
Knight Therapeutics CAD 599.03M 24.75M Sep/2024
Laboratorios Farma EUR 3.06B 257.39M Sep/2025
Neuren Pharmaceuticals AUD 1.6B 1.12B Dec/2024
Organigram Holdings CAD 222.95M 23.4M Sep/2025
Paradigm Biopharmaceuticals AUD 145.99M 56.79M Dec/2024
Pharma Mar EUR 1.39B 91.01M Jun/2025
Qiagen NV EUR 10.41B 2.39B Jun/2025
Ramsay Health Care AUD 7.95B 2.95B Dec/2024
ResMed AUD 43.83B 6B Sep/2025
Sartorius EUR 13.56B 794.37M Jun/2025
Tilray CAD 647.69M 211.12M Aug/2025
Zz Pientze Pharmaceu 120.67B 1.25B Jun/2025